Polymed Therapeutics has been at the forefront in the manufacture of APIs and Chemicals, with state-of-the-art and regulatory approved cGMP facilities and R&D laboratories. Our Fine Chemicals division specializes in Custom Manufacturing, and serves the global markets of Pharmaceutical and Specialty Chemicals. Our team of scientists is expert in the whole range, from R&D, pilot scale, to industrial scale manufacture. Being flexible and fast, our plants achieve extremely complex and simple synthesis, large and small demands. Our main reactions cover: Acylation, Amidation, Amination (Reductive), Asymmetric Synthesis, Azide Reactions, Butyl Lithium Chemistry, Carbohydrate Chemistry, Claisen Rearrangement, Cross Coupling Reactions (include: Heck Reaction, Suzuki Reaction), Cryogenic Reactions, Epoxidation, Esterification, Etherification, Friedel-Crafts Reaction, Grignard Reaction, Halogenation, Heterocyclic Synthesis, Hofmann Rearrangement, Hydrogenation (include: Catalytic Transfer Hydrogenation), Liquid Ammonia Reaction, Michael Addition, Alkylation (include: N- Alkylation, O-Alkylation), Nitration, Nucleophilic Substitution, Optical Resolution, Oxidation (include: Baeyer-Villiger OxidationjReduction, Chemical (include: Birch Reduction, Catalytic Reduction), Reformatsky Reaction, Sodium Dispersion Reactions, Substitutions, Sulfonation, Vilsmeier-Haack Reactions, Wurtz Reaction.Polymed is financially stable, technologically proficient and dedicated to providing the most excellent products and services at competitive costs, to be the optimal strategic supplier to global customers.
